You’re invited to attend an on-demand webinar to learn how a CE-MS method has been developed to quantitate a reduced monoclonal antibody in biological samples.
Richard Snell from GSK leads the presentation and will highlight the factors you need to consider when developing a CE-MS method to detect antibody fragments of 25 and 50kDa and show how injection and separation conditions can affect the sensitivity and peak resolution obtained. He will also demonstrate how using a surrogate mAb improves the reproducibility of electro-kinetic injections and highlights how CE-MS is now capable of detecting a mAb at low ng/ml sensitivities.
After viewing this on-demand webinar, you will understand:
You should view this on-demand webinar if you are:
Investigator, Bioanalysis, Immunogenicity & Biomarkers, IVIVT GSK